Exogenously supplied or gene-therapy delivered NGF has been proposed as alternative therapies for preservation of MS/DB neurons, maintenance of cholinergic function in the hippocampus, and attenuation of the progression of AD [10]–[12]. The gene discussed is NGF; the disease is Alzheimer disease.